YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / EDP Renovaveis S.A. (OTC PINK:EDRVF) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 3:00 PM Eastern Time. To listen to the event…
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / EDP Renovaveis S.A. (OTC PINK:EDRVF) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 3:00 PM Eastern Time. To listen to the event…
Los Angeles, CA, April 27, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid th…
Los Angeles, CA, April 24, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (the “Company”; OTCQB: APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid th…
Los Angeles, California, March 31, 2020 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTC: APPB) (the " Company"), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannab…
Los Angeles, CA, June 06, 2019 (GLOBE NEWSWIRE) -- Applied Biosciences Corp. (OTC: APPB), a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, announced that has offi…
LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on the medical, biopharmaceutical testing, consumer and veterinary health industries, annou…
LOS ANGELES, March 20, 2019 (GLOBE NEWSWIRE) -- Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that has signed a par…
LOS ANGELES, March 18, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and analytics and pet health industries, announced that it…
LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital dis…
LOS ANGELES, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that Dr. Xiang-Qun (Sean) Xie h…
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has acquired a majority…
LOS ANGELES, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has withdrawn its Regis…
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has entered into a Comm…
LOS ANGELES, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that it has expanded its produc…